Bioam Gestion

What is Bioam Gestion?

Bioam Gestion is an investment firm specializing in venture capital and providing seed capital to innovative sectors. They have a keen focus on technology, biotechnology, environment, life sciences, and healthcare sectors, aiming to support companies that embody strong growth potential and pioneering technologies. Bioam Gestion predominantly caters to companies based in France and Europe, nurturing a wide network within these regions to scout and support emerging talents and ideas.

Traditionally, they offer financial backing ranging from €2,000,000 to €34,500,000, positioning themselves as substantial contributors in their investments. Founded in the year 2000 and stationed in Paris, France, Bioam Gestion has established a firm presence within the European venture capital landscape. Their expertise is underscored by their history and successful track record of seed funding rounds which have enabled numerous companies to transition from early-stage to more mature phases of business development.

In July 2010, Bioam Gestion's expertise and position within the investment community were further solidified by an acquisition by CDC Entreprises, aligning with a broader strategy to invest in development and innovation across key sectors that are deemed critical for economic growth and sustainability.

Fuelled by a mission to empower and propel forward-thinking businesses, Bioam Gestion operates with a long-term investment philosophy, prioritizing sustainable growth and industry advancements.

With a focused investment thesis that aligns with evolving industry trends and societal needs, they continue to play a pivotal role in shaping the future of pertinent economic sectors through strategic funding and support of visionary entrepreneurs.